Protein scaffolds in human clinics

Aboushwareb, 2009, A keratin biomaterial gel hemostat derived from human hair: evaluation in a rabbit model of lethal liver injury, J. Biomed. Mater. Res. Part B Appl. Biomater., 90B, 45, 10.1002/jbm.b.31251 Achilli, 2012, On the viscoelastic properties of collagen-gel-based lattices under cyclic loading: applications for vascular tissue engineering, Macromol. Mater. Eng., 297, 724, 10.1002/mame.201100363 Ahmed, 2008, Fibrin: a versatile scaffold for tissue engineering applications, Tissue Eng. Part B Rev., 14, 199, 10.1089/ten.teb.2007.0435 Alamo, 2021, Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines, Acta Biomater. Alamo, 2021, Ion-dependent slow protein release from in vivo disintegrating micro-granules, Drug Deliv., 28, 2383, 10.1080/10717544.2021.1998249 Alsultan, 2016, Beyond antibodies: development of a novel protein scaffold based on human chaperonin 10, Sci. Rep., 6, 37348, 10.1038/srep37348 An, 2017, Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery, Theranostics, 7, 3667, 10.7150/thno.19365 Apel, 2008, Peripheral nerve regeneration using a keratin-based scaffold: long-term functional and histological outcomes in a mouse model, J. Hand Surg., 33, 1541, 10.1016/j.jhsa.2008.05.034 Arkudas, 2007, Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model, Mol. Med., 13, 480, 10.2119/2007-00057.Arkudas Beadle, 2002, Structural bases of stability-function tradeoffs in enzymes, J. Mol. Biol., 321, 285, 10.1016/S0022-2836(02)00599-5 Bhardwaj, 2016, Accurate de novo design of hyperstable constrained peptides, Nature, 538, 329, 10.1038/nature19791 Bhattacharjee, 2017, Silk scaffolds in bone tissue engineering: an overview, Acta Biomater., 63, 1, 10.1016/j.actbio.2017.09.027 Bichara, 2012, The tissue-engineered auricle: past, present, and future, Tissue Eng. Part B Rev., 18, 51, 10.1089/ten.teb.2011.0326 Bloom, 2009, FN3: a new protein scaffold reaches the clinic, Drug Discov. Today, 14, 949, 10.1016/j.drudis.2009.06.007 Boehr, 2018, Engineered control of enzyme structural dynamics and function, Protein Sci., 27, 825, 10.1002/pro.3379 Boekhoven, 2014, 25th anniversary article: supramolecular materials for regenerative medicine, Adv. Mater., 26, 1642, 10.1002/adma.201304606 Boskey, 2013, Bone composition: relationship to bone fragility and antiosteoporotic drug effects, BoneKEy Rep., 2, 447, 10.1038/bonekey.2013.181 Broadley, 2009, Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis, Mult. Scler., 15, 329, 10.1177/1352458508099141 Brule, 2016, Hierarchies of plant stiffness, Plant Sci.: Int. J. Exp. Plant Biol., 250, 79, 10.1016/j.plantsci.2016.06.002 Brunette, 2015, Exploring the repeat protein universe through computational protein design, Nature, 528, 580, 10.1038/nature16162 Burris, 2018, Climbing plants: attachment adaptations and bioinspired innovations, Plant Cell Rep., 37, 565, 10.1007/s00299-017-2240-y Canutescu, 2003, Cyclic coordinate descent: a robotics algorithm for protein loop closure, Protein Sci., 12, 963, 10.1110/ps.0242703 Cespedes, 2018, Selective depletion of metastatic stem cells as therapy for human colorectal cancer, EMBO Mol. Med., 10, e8772, 10.15252/emmm.201708772 Cespedes, 2018, Selective depletion of metastatic stem cells as therapy for human colorectal cancer, EMBO Mol. Med., 10, e8772, 10.15252/emmm.201708772 Cespedes, 2020, Engineering secretory amyloids for remote and highly selective destruction of metastatic foci, Adv. Mater., 32, 1907348, 10.1002/adma.201907348 Chandler, 2020, Development and differentiation in monobodies based on the fibronectin type 3 domain, Cells, 9, 10.3390/cells9030610 Chen, 1999, Tensegrity and mechanoregulation: from skeleton to cytoskeleton, Osteoarthr. Cartil., 7, 81, 10.1053/joca.1998.0164 Chen, 2010, Complexity of the tensegrity structure for dynamic energy and force distribution of cytoskeleton during cell spreading, PLoS One, 5, 10.1371/journal.pone.0014392 Chen, 2016, Albumin-NIR dye self-assembled nanoparticles for photoacoustic pH imaging and pH-responsive photothermal therapy effective for large tumors, Biomaterials, 98, 23, 10.1016/j.biomaterials.2016.04.041 Chen, 2019, Predicting HLA class II antigen presentation through integrated deep learning, Nat. Biotechnol., 37, 1332, 10.1038/s41587-019-0280-2 Chevalier, 2017, Massively parallel de novo protein design for targeted therapeutics, Nature, 550, 74, 10.1038/nature23912 Chien, 2013, In vivo acute and humoral response to three-dimensional porous soy protein scaffolds, Acta Biomater., 9, 8983, 10.1016/j.actbio.2013.07.005 Chien, 2013, Three-dimensional printing of soy protein scaffolds for tissue regeneration, Tissue Eng. Part C Methods, 19, 417, 10.1089/ten.tec.2012.0383 Corchero, 2013, Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics, Biotechnol. Adv., 31, 140, 10.1016/j.biotechadv.2012.09.001 Corchero, 2014, Recombinant protein materials for bioengineering and nanomedicine, Nanomedicine, 9, 2817, 10.2217/nnm.14.153 Corrales-Ureña, 2017, Extracellular micro and nanostructures forming the velvet worm solidified adhesive secretion, Mater. Res. Express, 4, 10.1088/2053-1591/aa9940 Costa, 2018, 7 - Fibrous protein-based biomaterials (silk, keratin, elastin, and resilin proteins) for tissue regeneration and repair, 175 Criscitiello, 2021, Antibody-drug conjugates in solid tumors: a look into novel targets, J. Hematol. Oncol., 14, 10.1186/s13045-021-01035-z Daamen, 2007, Elastin as a biomaterial for tissue engineering, Biomaterials, 28, 4378, 10.1016/j.biomaterials.2007.06.025 Dalby, 2014, Harnessing nanotopography and integrin–matrix interactions to influence stem cell fate, Nat. Mater., 13, 558, 10.1038/nmat3980 Davis, 2007, Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity, J. Rheumatol., 34, 2204 de Marco, 2019, Bacterial inclusion bodies are industrially exploitable amyloids, FEMS Microbiol. Rev., 43, 53, 10.1093/femsre/fuy038 De Santis, 2011, How can cells sense the elasticity of a substrate? An analysis using a cell tensegrity model, Eur. Cells Mater., 22, 202, 10.22203/eCM.v022a16 Deville, 2019, The extracellular, cellular, and nuclear stiffness, a trinity in the cancer resistome—a review, Front. Oncol., 9 Ding, 2021, Three-dimensional silk fibroin scaffolds incorporated with graphene for bone regeneration, J. Biomed. Mater. Res. A, 109A, 515, 10.1002/jbm.a.37034 Dobrovolskaia, 2016, Current understanding of interactions between nanoparticles and the immune system, Toxicol. Appl. Pharmacol., 299, 78, 10.1016/j.taap.2015.12.022 Duan, 2021, Targeting macrophages in cancer immunotherapy, Signal Transduct. Target. Ther., 6, 127, 10.1038/s41392-021-00506-6 Elmowafy, 2019, Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles, J. Pharm. Investig., 49, 347, 10.1007/s40005-019-00439-x Epler Barbercheck, 2018, Bacterial adhesion pili, Subcell. Biochem., 87, 1, 10.1007/978-981-10-7757-9_1 Evans, 2008, Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays, J. Biol., 7, 10.1186/jbiol62 Fernández-Colino, 2018, Macroporous click-elastin-like hydrogels for tissue engineering applications, Mater. Sci. Eng. C, 88, 140, 10.1016/j.msec.2018.03.013 Fleishman, 2022, Editorial overview: engineering and design, Curr. Opin. Struct. Biol., 75, 10.1016/j.sbi.2022.102437 Fujii, 2004, Preparation of translucent and flexible human hair protein films and their properties, Biol. Pharm. Bull., 27, 1433, 10.1248/bpb.27.1433 Getmanova, 2006, Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro, Chem. Biol., 13, 549, 10.1016/j.chembiol.2005.12.009 Glaesner, 2010, Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein, Diabetes Metab. Res. Rev., 26, 287, 10.1002/dmrr.1080 Goldberg, 2016, Engineering a targeted delivery platform using Centyrins, Protein Eng. Des. Sel.: PEDS, 29, 563 Gong, 2013, N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance, Mol. Pharm., 10, 2642, 10.1021/mp400075f Gradishar, 2006, Albumin-bound paclitaxel: a next-generation taxane, Expert. Opin. Pharmacother., 7, 1041, 10.1517/14656566.7.8.1041 Guimarães, 2020, The stiffness of living tissues and its implications for tissue engineering, Nat. Rev. Mater., 10.1038/s41578-019-0169-1 Hallahan, 2009, Analysis of gene expression in gecko digital adhesive pads indicates significant production of cysteine- and glycine-rich beta-keratins, J. Exp. Zool. B: Mol. Dev. Evol., 312, 58, 10.1002/jez.b.21242 Hansen, 2020, Recent progress in designing protein-based supramolecular assemblies, Curr. Opin. Struct. Biol., 63, 106, 10.1016/j.sbi.2020.05.001 Herzberg, 1991, Analysis of the steric strain in the polypeptide backbone of protein molecules, Proteins, 11, 223, 10.1002/prot.340110307 Hill, 2018, Engineering virus-like particles for antigen and drug delivery, Curr. Protein Pept. Sci., 19, 112 Hoffmann, 2010, Structure-function studies of an engineered scaffold protein derived from stefin A. I: development of the SQM variant, Protein Eng. Des. Sel., 23, 403, 10.1093/protein/gzq012 Hopf, 2001, Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1, Nat. Struct. Biol., 8, 634, 10.1038/89683 Hu, 2015, Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects, Chem. Commun., 51, 11405, 10.1039/C5CC04035C Huang, 2016, The coming of age of de novo protein design, Nature, 537, 320, 10.1038/nature19946 Huck, 2008, Responsive polymers for nanoscale actuation, Mater. Today, 11, 24, 10.1016/S1369-7021(08)70146-9 Hussey, 2018, Extracellular matrix-based materials for regenerative medicine, Nat. Rev. Mater., 3, 159, 10.1038/s41578-018-0023-x Jacobs, 2012, Design of novel FN3 domains with high stability by a consensus sequence approach, Protein Eng. Des. Sel., 25, 107, 10.1093/protein/gzr064 Jacobs, 2016, Design of structurally distinct proteins using strategies inspired by evolution, Science, 352, 687, 10.1126/science.aad8036 Jain, 2007, Engineering antibodies for clinical applications, Trends Biotechnol., 25, 307, 10.1016/j.tibtech.2007.05.001 Jen, 2018, FDA approval: gemtuzumab ozogamicin for the treatment of adults with newly diagnosed cd33-positive acute myeloid leukemia, Clin. Cancer Res., 24, 3242, 10.1158/1078-0432.CCR-17-3179 Jen, 2020, FDA approval summary: tagraxofusp-erzs for treatment of blastic plasmacytoid dendritic cell neoplasm, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 26, 532, 10.1158/1078-0432.CCR-19-2329 Jenko, 2003, Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases, J. Mol. Biol., 326, 875, 10.1016/S0022-2836(02)01432-8 Kadkhoda, 2021, Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends, Int. J. Biol. Macromol., 185, 664, 10.1016/j.ijbiomac.2021.06.191 Keam, 2020, Trastuzumab Deruxtecan: first approval, Drugs, 80, 501, 10.1007/s40265-020-01281-4 Khademi, 2018, Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: a systematic review, Iran. J. Basic Med. Sci., 21, 116 Khirehgesh, 2021, Immunotoxins and nanobody-based immunotoxins: review and update, J. Drug Target., 29, 848, 10.1080/1061186X.2021.1894435 Klein, 2021, Centyrin ligands for extrahepatic delivery of siRNA, Mol. Ther.: J. Am. Soc. Gene Ther., 29, 2053, 10.1016/j.ymthe.2021.02.015 Klem, 2008, Photochemical mineralization of europium, titanium, and iron oxyhydroxide nanoparticles in the ferritin protein cage, Inorg. Chem., 47, 2237, 10.1021/ic701740q Kneser, 2005, Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute, Cells Tissues Organs, 179, 158, 10.1159/000085951 Koide, 1998, The fibronectin type III domain as a scaffold for novel binding proteins, J. Mol. Biol., 284, 1141, 10.1006/jmbi.1998.2238 Kreitman, 2021, Immunotoxins: from design to clinical application, Biomolecules, 11, 1696, 10.3390/biom11111696 Kuhlman, 2003, Design of a novel globular protein fold with atomic-level accuracy, Science, 302, 1364, 10.1126/science.1089427 Kumar, 2014, Cellular mechanotransduction: stiffness does matter, Nat. Mater., 13, 918, 10.1038/nmat4094 Kundu, 2012, Silk fibroin/poly(vinyl alcohol) photocrosslinked hydrogels for delivery of macromolecular drugs, Acta Biomater., 8, 1720, 10.1016/j.actbio.2012.01.004 Lagasse, 2017, Recent advances in (therapeutic protein) drug development, F1000Research, 6, 113, 10.12688/f1000research.9970.1 Lee, 2018, Emerging properties of hydrogels in tissue engineering, J. Tissue Eng., 9, 10.1177/2041731418768285 LeVeau, 1984, Developmental biomechanics. Effect of forces on the growth, development, and maintenance of the human body, Phys. Ther., 64, 1874, 10.1093/ptj/64.12.1874 Li, 2018, Enzyme replacement therapy: a review and its role in treating lysosomal storage diseases, Pediatr. Ann., 47, e191, 10.3928/19382359-20180424-01 Li, 2014, A novel albumin-based tissue scaffold for autogenic tissue engineering applications, Sci. Rep., 4, 5600, 10.1038/srep05600 Liang, 2010, EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results, BMC Bioinform., 11, 381, 10.1186/1471-2105-11-381 Liu, 2019, The state-of-the-art strategies of protein engineering for enzyme stabilization, Biotechnol. Adv., 37, 530, 10.1016/j.biotechadv.2018.10.011 López-Laguna, 2021, In vitro fabrication of microscale secretory granules, Adv. Funct. Mater., 31, 2100914, 10.1002/adfm.202100914 Lorentz, 2011, Engineered aprotinin for improved stability of fibrin biomaterials, Biomaterials, 32, 430, 10.1016/j.biomaterials.2010.08.109 Lu, 2021, Antibody–drug conjugates in cancer therapy, 1, 102 Ma, 2013, Paclitaxel nano-delivery systems: a comprehensive review, J. Nanomed. Nanotechnol., 4, 1000164, 10.4172/2157-7439.1000164 Mahalingam, 2017, Evaluation of a centyrin-based near-infrared probe for fluorescence-guided surgery of epidermal growth factor receptor positive tumors, Bioconjug. Chem., 28, 2865, 10.1021/acs.bioconjchem.7b00566 Marchetti, 2022, Enzyme replacement therapy for genetic disorders associated with enzyme deficiency, Curr. Med. Chem., 29, 489, 10.2174/0929867328666210526144654 Martinez-Miguel, 2020, Stable anchoring of bacteria-based protein nanoparticles for surface enhanced cell guidance, J. Mater. Chem. B, 8, 5080, 10.1039/D0TB00702A Merlot, 2014, Unraveling the mysteries of serum albumin—more than just a serum protein, Front. Physiol., 5 Merrett, 2009, Synthetic neoglycopolymer-recombinant human collagen hybrids as biomimetic crosslinking agents in corneal tissue engineering, Biomaterials, 30, 5403, 10.1016/j.biomaterials.2009.06.016 Mogosanu, 2014, Keratin-based biomaterials for biomedical applications, Curr. Drug Targets, 15, 518, 10.2174/1389450115666140307154143 Molino, 2014, Caged protein nanoparticles for drug delivery, Curr. Opin. Biotechnol., 28, 75, 10.1016/j.copbio.2013.12.007 Murphy, 2012, Increasing sequence diversity with flexible backbone protein design: the complete redesign of a protein hydrophobic core, Structure, 20, 1086, 10.1016/j.str.2012.03.026 Narayanan, 2021, Machine learning for biologics: opportunities for protein engineering, developability, and formulation, Trends Pharmacol. Sci., 42, 151, 10.1016/j.tips.2020.12.004 Noh, 2015, A dual delivery of substance P and bone morphogenetic protein-2 for mesenchymal stem cell recruitment and bone regeneration, Tissue Eng. Part A, 21, 1275, 10.1089/ten.tea.2014.0182 O'Donnell, 2020, MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing, Cell Syst., 11, 42, 10.1016/j.cels.2020.06.010 Orellana, 2019, Large-scale conformational changes and protein function: breaking the in silico barrier, Front. Mol. Biosci., 6 Pallares, 2020, An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination, J. Hematol. Oncol., 13, 36, 10.1186/s13045-020-00863-9 Park, 2019, Cation−π interactions and their contribution to mussel underwater adhesion studied using a surface forces apparatus: a mini-review, Langmuir: ACS J. surf. Colloids, 35, 16002, 10.1021/acs.langmuir.9b01976 Parmeggiani, 2017, Designing repeat proteins: a modular approach to protein design, Curr. Opin. Struct. Biol., 45, 116, 10.1016/j.sbi.2017.02.001 Peretti, 2006, Review of injectable cartilage engineering using fibrin gel in mice and swine models, Tissue Eng., 12, 1151, 10.1089/ten.2006.12.1151 Ponomarenko, 2008, ElliPro: a new structure-based tool for the prediction of antibody epitopes, BMC Bioinform., 9, 514, 10.1186/1471-2105-9-514 Prabakaran, 2008, Structure of an isolated unglycosylated antibody C(H)2 domain, Acta Crystallogr. D Biol. Crystallogr., 64, 1062, 10.1107/S0907444908025274 Radziwon, 2021, Protein engineering for selective proteomics, Curr. Opin. Chem. Biol., 60, 10, 10.1016/j.cbpa.2020.07.003 Raftis, 2019, Nanoparticle translocation and multi-organ toxicity: a particularly small problem, Nano Today, 26, 8, 10.1016/j.nantod.2019.03.010 Ramji, 2014, Electrospun soy protein nanofiber scaffolds for tissue regeneration, J. Biomater. Appl., 29, 411, 10.1177/0885328214530765 Reynisson, 2020, NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data, Nucleic Acids Res., 48, W449, 10.1093/nar/gkaa379 Richardson, 2019, FDA approval summary: brentuximab vedotin in first-line treatment of peripheral T-cell lymphoma, Oncologist, 24, e180, 10.1634/theoncologist.2019-0098 Rouse, 2010, A review of keratin-based biomaterials for biomedical applications, Materials (Basel, Switzerland), 3, 999, 10.3390/ma3020999 Rubinstein, 2009, Epitopia: a web-server for predicting B-cell epitopes, BMC Bioinform., 10, 287, 10.1186/1471-2105-10-287 Sanchez, 2020, Artificial inclusion bodies for clinical development, Adv. Sci., 7, 1902420, 10.1002/advs.201902420 Sánchez, 2022, The poly-histidine tag H6 mediates structural and functional properties of disintegrating, protein-releasing inclusion bodies, Pharmaceutics, 14, 602, 10.3390/pharmaceutics14030602 Sanchez-Garcia, 2016, Recombinant pharmaceuticals from microbial cells: a 2015 update, Microb. Cell Factories, 15, 33, 10.1186/s12934-016-0437-3 Sanchez-Trincado, 2017, Fundamentals and methods for T- and B-cell epitope prediction, J Immunol Res, 2017, 2680160, 10.1155/2017/2680160 Sauerborn, 2010, Immunological mechanism underlying the immune response to recombinant human protein therapeutics, Trends Pharmacol. Sci., 31, 53, 10.1016/j.tips.2009.11.001 Schafmeister, 1997, A designed four helix bundle protein with native-like structure, Nat. Struct. Biol., 4, 1039, 10.1038/nsb1297-1039 Schreiber, 1994, Stability and function: two constraints in the evolution of barstar and other proteins, Structure, 2, 945, 10.1016/S0969-2126(94)00096-4 Seras-Franzoso, 2014, Improving protein delivery of fibroblast growth factor-2 from bacterial inclusion bodies used as cell culture substrates, Acta Biomater., 10, 1354, 10.1016/j.actbio.2013.12.021 Seras-Franzoso, 2015, Integrating mechanical and biological control of cell proliferation through bioinspired multieffector materials, Nanomedicine, 10, 873, 10.2217/nnm.15.5 Serna, 2018, Protein-based therapeutic killing for cancer therapies, Trends Biotechnol., 36, 318, 10.1016/j.tibtech.2017.11.007 Serna, 2020, Release of functional fibroblast growth factor-2 from artificial inclusion bodies, J. Control. Release: Off. J. Control. Release Soc., 327, 61, 10.1016/j.jconrel.2020.08.007 Serna, 2022, Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery, J. Control. Release, 343, 277, 10.1016/j.jconrel.2022.01.017 Shah, 2018, Stimuli-responsive peptide-based biomaterials as drug delivery systems, Chem. Eng. J., 353, 559, 10.1016/j.cej.2018.07.126 Shen, 2019, Fusion of thymosin alpha 1 with mutant IgG1 CH3 prolongs half-life and enhances antitumor effects in vivo, Int. Immunopharmacol., 74, 10.1016/j.intimp.2019.05.047 Shi, 2018, LC/MS/MS bioanalysis of protein-drug conjugates-the importance of incorporating succinimide hydrolysis products, Anal. Chem., 90, 5314, 10.1021/acs.analchem.8b00411 Sierpinski, 2008, The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves, Biomaterials, 29, 118, 10.1016/j.biomaterials.2007.08.023 Silva, 2018, Structures and disulfide cross-linking of de novo designed therapeutic mini-proteins, FEBS J., 285, 1783, 10.1111/febs.14394 Silva, 2019, De novo design of potent and selective mimics of IL-2 and IL-15, Nature, 565, 186, 10.1038/s41586-018-0830-7 Smith, 2002, The structure and function of adhesive gels from invertebrates, Integr. Comp. Biol., 42, 1164, 10.1093/icb/42.6.1164 Song, 2011, Peptide aptamer microarrays: bridging the bio-detector interface, Faraday Discuss., 149, 79, 10.1039/C005376G Spotnitz, 2014, Fibrin sealant: the only approved hemostat, sealant, and adhesive—a laboratory and clinical perspective, ISRN Surg., 2014, 10.1155/2014/203943 Stadler, 2011, Structure-function studies of an engineered scaffold protein derived from Stefin A. II: development and applications of the SQT variant, Protein Eng. Des. Sel.: PEDS, 24, 751, 10.1093/protein/gzr019 Stadler, 2014, The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function, Cell Death Dis., 5, e1037, 10.1038/cddis.2013.564 Stamm, 2018, Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl, Microb. Cell Factories, 17, 57, 10.1186/s12934-018-0904-0 Stein, 2013, Improvements to robotics-inspired conformational sampling in rosetta, PLoS One, 8, 10.1371/journal.pone.0063090 Sun, 2009, SEPPA: a computational server for spatial epitope prediction of protein antigens, Nucleic Acids Res., 37, W612, 10.1093/nar/gkp417 Suzuki, 2013, Gelatin gel as a carrier of platelet-derived growth factors, J. Biomater. Appl., 28, 595, 10.1177/0885328212468183 Sweredoski, 2008, PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure, Bioinformatics, 24, 1459, 10.1093/bioinformatics/btn199 Takagi, 2003, Complex between nidogen and laminin fragments reveals a paradigmatic β-propeller interface, Nature, 424, 969, 10.1038/nature01873 Tatkiewicz, 2018, Surface-bound gradient deposition of protein nanoparticles for cell motility studies, ACS Appl. Mater. Interfaces, 10, 25779, 10.1021/acsami.8b06821 Taylor, 2006, Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model, J. Control. Release, 116, 204, 10.1016/j.jconrel.2006.07.005 Tiwari, 2021, A review on albumin as a biomaterial for ocular drug delivery, Int. J. Biol. Macromol., 191, 591, 10.1016/j.ijbiomac.2021.09.112 Ulijn, 2020, Order/disorder in protein and peptide-based biomaterials, Isr. J. Chem., 10.1002/ijch.201900051 van Beers, 2010, On the role of aggregates in the immunogenicity of recombinant human interferon beta in patients with multiple sclerosis, J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res., 30, 767, 10.1089/jir.2010.0086 Venkatesh, 2020, MHCAttnNet: predicting MHC-peptide bindings for MHC alleles classes I and II using an attention-based deep neural model, Bioinformatics, 36, i399, 10.1093/bioinformatics/btaa479 Volokh, 2011, On tensegrity in cell mechanics, Mol. Cell. Biomech.: MCB, 8, 195 Volokh, 2002, Cell cytoskeleton and tensegrity, Biorheology, 39, 63 Wang, 2020, Biological and bioinspired materials: structure leading to functional and mechanical performance, Bioact. Mater., 5, 745, 10.1016/j.bioactmat.2020.06.003 Wilding, 2019, Protein engineering: the potential of remote mutations, Biochem. Soc. Trans., 47, 701, 10.1042/BST20180614 Wilkinson, 2021, Fc-engineered antibodies with immune effector functions completely abolished, PLoS One, 16, e0260954, 10.1371/journal.pone.0260954 Wong, 2021, Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors, J. Immunother. Cancer, 9, 10.1136/jitc-2020-001945 Woodman, 2005, Design and validation of a neutral protein scaffold for the presentation of peptide aptamers, J. Mol. Biol., 352, 1118, 10.1016/j.jmb.2005.08.001 Worth, 2009, Satisfaction of hydrogen-bonding potential influences the conservation of polar sidechains, Proteins, 75, 413, 10.1002/prot.22248 Wu, 2018, Rationally designed synthetic protein hydrogels with predictable mechanical properties, Nat. Commun., 9, 620, 10.1038/s41467-018-02917-6 Xu, 2020, Natural protein bioinspired materials for regeneration of hard tissues, J. Mater. Chem. B, 8, 2199, 10.1039/D0TB00139B Yang, 2010, Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2, Tissue Eng. Part A, 16, 1225, 10.1089/ten.tea.2009.0390 Yang, 2011, Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery, Tissue Eng. Part A, 17, 1809, 10.1089/ten.tea.2010.0540 Yarger, 2018, Uncovering the structure–function relationship in spider silk, Nat. Rev. Mater., 3, 18008, 10.1038/natrevmats.2018.8 Ying, 2012, Soluble monomeric IgG1 Fc, J. Biol. Chem., 287, 19399, 10.1074/jbc.M112.368647 Ying, 2013, Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics, J. Biol. Chem., 288, 25154, 10.1074/jbc.M113.484154 Ying, 2014, Engineered Fc based antibody domains and fragments as novel scaffolds, Biochim. Biophys. Acta, Proteins Proteomics, 1844, 1977, 10.1016/j.bbapap.2014.04.018 Yuan, 2019, Cellular toxicity and immunological effects of carbon-based nanomaterials, Part. Fibre Toxicol., 16, 18, 10.1186/s12989-019-0299-z Zahavi, 2020, Monoclonal antibodies in cancer therapy, Antibodies (Basel, Switzerland), 9 Zalar, 2019, New disulphide bond in cystatin-based protein scaffold prevents domain-swap-mediated oligomerization and stabilizes the functionally active form, ACS Omega, 4, 18248, 10.1021/acsomega.9b02269 Zalar, 2019, Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold, Sci. Rep., 9, 9067, 10.1038/s41598-019-45565-6 Zhen, 2013, RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors, ACS Nano, 7, 4830, 10.1021/nn305791q